Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH [Phase 2]

View source ↗

Summary

A Phase 2 study (CBD-OH) is evaluating cannabidiol as an add-on treatment during inpatient alcohol cessation for severe alcohol use disorder. The trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Severe Alcohol Use Disorder (DSM 5) | Phase 2 | Status: RECRUITING